BREAKTHROUGHS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sphere of biopharmaceuticals, providing promising breakthroughs across several health care and industrial purposes. With its structural similarity to Normally derived human serum albumin, OsrHSA delivers a safer, more reliable alternative for therapeutic use, notably